Is CBLUY or JNJ a better dividend investment in 2026?

CBLUY currently yields 7.48% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CBLUY offers higher current income.

What is the dividend yield difference between CBLUY and JNJ?

CBLUY has a forward dividend yield of 7.48% ($0.84/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 4.12 percentage points.

Home › Compare › CBLUY vs JNJ

CBLUY vs JNJ: Dividend Comparison 2026

CBLUY yields 7.48% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CBLUY wins by $5.16M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CBLUY

● Live price

7.48%

Share price

$11.19

Annual div

$0.84

5Y div CAGR

53.9%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.18M

Annual income

$3,831,602.41

Full CBLUY calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CBLUY vs JNJ

📍 CBLUY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CBLUY	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CBLUY + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CBLUY pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBLUY

Annual income on $10K today (after 15% tax)

$635.43/yr

After 10yr DRIP, annual income (after tax)

$3,256,862.05/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, CBLUY beats the other by $3,256,158.44/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBLUY + JNJ for your $10,000?

CBLUY: 50%JNJ: 50%

100% JNJ50/50100% CBLUY

Portfolio after 10yr

$2.60M

Annual income

$1,916,215.10/yr

Blended yield

73.64%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CBLUY

No analyst data

Altman Z

2.5

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBLUY buys

JNJ buys

No recent congressional trades found for CBLUY or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCBLUYJNJ

Forward yield	7.48% ✓	3.36%
Annual dividend / share	$0.84	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	53.9% ✓	5.8%
Portfolio after 10y	$5.18M	$20.0K ✓
Annual income after 10y	$3,831,602.41 ✓	$827.78
Total dividends collected	$5.03M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CBLUY vs JNJ ($10,000, DRIP)

Year	CBLUY Portfolio	CBLUY Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,850	$1,150.50	$10,676	$355.77	+$1.2K → CBLUY
2	$14,641	$1,960.99	$11,407	$389.39	+$3.2K → CBLUY
3	$19,151	$3,484.70	$12,198	$426.53	+$7.0K → CBLUY
4	$27,047	$6,555.89	$13,056	$467.62	+$14.0K → CBLUY
5	$42,258	$13,317.54	$13,987	$513.12	+$28.3K → CBLUY
6	$75,143	$29,927.24	$14,998	$563.56	+$60.1K → CBLUY
7	$156,946	$76,542.62	$16,098	$619.52	+$140.8K → CBLUY
8	$397,874	$229,942.06	$17,295	$681.69	+$380.6K → CBLUY
9	$1,264,160	$838,434.63	$18,599	$750.82	+$1.25M → CBLUY
10	$5,184,253	$3,831,602.41	$20,022	$827.78	+$5.16M → CBLUY

CBLUY vs JNJ: Complete Analysis 2026

CBLUY — Stock

China BlueChemical Ltd., together with its subsidiaries, develops, manufactures, and sells mineral fertilizers and chemical products in the People's Republic of China and internationally. The company operates through Urea, Phosphorus and Compound Fertiliser, Methanol, and Others segments. It offers urea; mono-ammonium phosphate, di-ammonium phosphate, and compound fertilizers; methanol; and bulk blending fertilizers, and polyformaldehyde and woven plastic bags. The company is also involved in the trading of fertilizers and chemicals; mining, processing, manufacturing, and selling of phosphate; port operations; and provision of preparatory work for methanol and dimethyl-ether projects. In addition, it offers transportation and overseas shipping services; and manufactures and sells acrylonitrile and methyl methacrylate. The company was formerly known as CNOOC Chemical Limited and changed its name to China BlueChemical Ltd. in April 2006. The company was founded in 2000 and is headquartered in Beijing, the People's Republic of China. China BlueChemical Ltd. is a subsidiary of China National Offshore Oil Corporation.

Full CBLUY Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CBLUY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBLUY vs SCHD CBLUY vs JEPI CBLUY vs O CBLUY vs KO CBLUY vs MAIN CBLUY vs ABBV CBLUY vs MRK CBLUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.